President Donald Asset On Friday, signed four executive orders aimed at reducing some prices that U.S. citizens pay for prescription drugs that may have appeal as he faces a re-election battle and fierce criticism over his handling of the coronavirus pandemic .
In a ceremony at the White House, Trump outlined his plan to sign four executive orders regarding drug prices. One concerns importation. The others would give discounts to drugmakers directly to patients and provide insulin and EpiPens at steep discounts to low-income people.
The fourth, which may not need to be implemented if negotiations with drug companies are successful, would require Medicare to purchase drugs at the same price as other countries, Asset he told me.
Democrats are eager to contrast Trump’s orders with their ambitious plans to allow Medicare to negotiate prices with drug companies, an idea the president had supported as a candidate.
Consumers may not notice many immediate changes from the new prescriptions, which must be executed by the federal bureaucracy and could face legal challenges.
Trump took office complaining that drug companies “got away with murder” and vowing to get them under control. Almost four years later, things are much the same despite some recent moderation in price increases.
The will to pass important legislation this year has been blocked in Congress. Although Trump has told Republican senators that lowering prescription prices is “something you have to do,” many remain reluctant to use federal authority to force drugmakers to charge less.
Meanwhile, Democrats in Congress calculate the election will strengthen their hand, and they’ll finally be able to pass a law that allows Medicare to negotiate prices directly.
Neither side in Congress was pressured to negotiate, and the White House was unable to implement Trump’s will.
Last year, the House passed Pelosi’s Medicare negotiations bill, which would also have capped drug costs for seniors and expanded program benefits. He had no way forward in the Senate and the White House called him “unachievable.”
But there was an alternative. A bipartisan Senate bill backed by Trump did not give Medicare bargaining power, but would have limited annual price increases and capped costs for seniors. The bill was passed by a Senate committee, but was never presented to the whole body.
“It is unclear why the administration did not make a greater effort to line up the votes to get a bill through the Senate and a deal with Congress, given the strong public support for lowering costs. drugs, ”Tricia Neuman, a Medicare expert with the non-partisan Kaiser Family Foundation, told the Associated Press news agency.
White House press secretary Kayleigh McEnany said in a statement that the executive orders “follow a long list of decisive steps President Trump has taken to reduce prescription drug costs and keep his promise to guarantee every American l ‘access to better health care at a lower cost’.
U.S. citizens remain concerned about drug costs, with nearly nine in 10 saying in a recent Gallup-West Health poll that they feared the pharmaceutical industry would take advantage of the coronavirus pandemic to raise prices.
Another Gallup-West Health survey earlier this year found that 65% of respondents said the Trump administration had made little or no progress in limiting the increase in prescription drug costs.
The pharmaceutical industry is adamantly opposed to the government’s efforts to cut prices and has strongly opposed earlier versions of the proposals in Trump’s new orders.
Ads run by industry-aligned groups are already running ads opposing the measures, calling the plan to use the international prices of some Medicare drugs “socialist,” without mentioning Trump by name.
Trump is currently following Democratic challenger Joe Biden by around nine points, according to the Real Clear Politics average of all general election polls.
Observers note that Trump’s handling of the coronavirus pandemic may have cost him the support of many demographic groups, including the elderly, who vote in large numbers but are most likely to die from COVID-19, the disease caused by the virus.
The Trump administration has been criticized for its lax approach to the pandemic. Trump has backed calls to reopen states so their economies can rebound.
Drug prices are a particularly important issue for older people, who rely on drugs to manage the onslaught of medical problems associated with old age.
Trump said at the ceremony that Americans were his “most important” concern.
The United States currently leads the world with more than four million confirmed cases of coronavirus and 145,000 deaths, according to the Johns Hopkins University tally.